首页 > 最新文献

Microbiology insights最新文献

英文 中文
Echinocandin Resistance in Aspergillus fumigatus Has Broad Implications for Membrane Lipid Perturbations That Influence Drug-Target Interactions. 烟曲霉对棘白菌素的耐药性与影响药物-靶标相互作用的膜脂扰动有关。
Pub Date : 2019-12-31 eCollection Date: 2019-01-01 DOI: 10.1177/1178636119897034
Shruthi Satish, David S Perlin

Echinocandin drugs target the fungal enzyme β-(1,3)-glucan synthase (GS), which is required for the synthesis of cell wall component β-(1,3)-d-glucan. They are first-line therapy for Candida infections but are increasingly used as second-line therapy for Aspergillus infections. Resistance to echinocandins has been mainly studied in Candida and occurs due to mutations in FKS genes encoding GS. In our recent report, we identified a novel mechanism of echinocandin resistance in Aspergillus fumigatus. We showed that caspofungin exposure modifies GS, rendering it insensitive to echinocandins. This mechanism of resistance involved alteration of the GS lipid microenvironment and was mediated via an off-target effect on mitochondria leading to increased reactive oxygen species (ROS). We hypothesized that caspofungin-induced ROS alters the lipid composition around GS, changing its conformation and making it insensitive to echinocandins. In this commentary, we review both fks1-dependent and fks1-independent mechanisms of echinocandin resistance in A fumigatus. We believe this new resistance mechanism is also conserved among Candida spp. with implications for drug tolerance and/or resistance. Furthermore, we propose that ROS acts as a signaling molecule regulating lipid biogenesis, which impacts the structure-function of membrane proteins with implications for other types of drug-target interactions.

棘白菌素药物靶向真菌酶β-(1,3)-葡聚糖合成酶(GS),该酶是合成细胞壁成分β-(1,3)-d-葡聚糖所必需的。它们是念珠菌感染的一线治疗,但越来越多地被用作曲霉感染的二线治疗。对棘白菌素的抗性主要在念珠菌中研究,它是由于编码GS的FKS基因突变而产生的。在我们最近的报告中,我们发现了烟曲霉对棘白菌素耐药的一种新机制。我们发现暴露于caspofungin可以改变GS,使其对棘白菌素不敏感。这种抗性机制涉及GS脂质微环境的改变,并通过线粒体的脱靶效应介导,导致活性氧(ROS)增加。我们假设caspofunins诱导的ROS改变了GS周围的脂质组成,改变了其构象,使其对棘白菌素不敏感。在这篇评论中,我们综述了烟曲霉对棘白菌素的抗性机制,包括依赖和不依赖fks1的机制。我们相信这种新的耐药机制在念珠菌中也是保守的,对药物耐受性和/或耐药性具有影响。此外,我们提出ROS作为调节脂质生物发生的信号分子,影响膜蛋白的结构-功能,并影响其他类型的药物-靶标相互作用。
{"title":"Echinocandin Resistance in <i>Aspergillus fumigatus</i> Has Broad Implications for Membrane Lipid Perturbations That Influence Drug-Target Interactions.","authors":"Shruthi Satish,&nbsp;David S Perlin","doi":"10.1177/1178636119897034","DOIUrl":"https://doi.org/10.1177/1178636119897034","url":null,"abstract":"<p><p>Echinocandin drugs target the fungal enzyme β-(1,3)-glucan synthase (GS), which is required for the synthesis of cell wall component β-(1,3)-d-glucan. They are first-line therapy for <i>Candida</i> infections but are increasingly used as second-line therapy for <i>Aspergillus</i> infections. Resistance to echinocandins has been mainly studied in <i>Candida</i> and occurs due to mutations in <i>FKS</i> genes encoding GS. In our recent report, we identified a novel mechanism of echinocandin resistance in <i>Aspergillus fumigatus</i>. We showed that caspofungin exposure modifies GS, rendering it insensitive to echinocandins. This mechanism of resistance involved alteration of the GS lipid microenvironment and was mediated via an off-target effect on mitochondria leading to increased reactive oxygen species (ROS). We hypothesized that caspofungin-induced ROS alters the lipid composition around GS, changing its conformation and making it insensitive to echinocandins. In this commentary, we review both <i>fks1-</i>dependent and <i>fks1</i>-independent mechanisms of echinocandin resistance in <i>A fumigatus</i>. We believe this new resistance mechanism is also conserved among <i>Candida</i> spp. with implications for drug tolerance and/or resistance. Furthermore, we propose that ROS acts as a signaling molecule regulating lipid biogenesis, which impacts the structure-function of membrane proteins with implications for other types of drug-target interactions.</p>","PeriodicalId":74187,"journal":{"name":"Microbiology insights","volume":"12 ","pages":"1178636119897034"},"PeriodicalIF":0.0,"publicationDate":"2019-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1178636119897034","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39814401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Pathogens Causing Respiratory Tract Infections in Children Less Than 5 Years of Age in Senegal. 塞内加尔5岁以下儿童引起呼吸道感染的病原体。
Pub Date : 2019-12-30 eCollection Date: 2019-01-01 DOI: 10.1177/1178636119890885
Rebecca B Knobbe, Abdallah Diallo, Amary Fall, Aida D Gueye, Assane Dieng, Tabitha D van Immerzeel, Abou Ba, Amadou Diop, Abdoulaye Diop, Mbayame Niang, Cheikh Sb Boye

Introduction: While acute respiratory tract infections are the main cause of paediatric mortality and morbidity worldwide, pathogen patterns shift due to factors such as hygiene, vaccinations, and antibiotic resistance. Knowledge about current cause of respiratory infections is lacking, particularly in low- and middle-income countries. The aim of this study was to identity the various respiratory pathogens causing acute respiratory tract infections in children below 5 years of age visiting a sub-urban primary care clinic in Senegal.

Methods: A case-control study was performed in September and October 2018. Oropharyngeal swabs were collected from cases; infants with fever and respiratory symptoms, and controls; children involved in the vaccination programme. Viral identification was conducted by polymerase chain reaction for 21 different viruses; bacteria were identified by culture studies. Associations between microorganisms, acute respiratory infection and severity of disease were calculated by multivariate regression adjusting for confounders such as age, sex, and living area.

Results: Overall, 102 cases and 96 controls were included. Microorganisms were detected in 90.1% of cases and 53.7% of controls (P < .001). Influenza virus A (including H1N1), influenza virus B, respiratory syncytial virus (RSV), and Streptococcus pneumoniae were independently associated with acute respiratory tract infections. Co-detection of two or more pathogens was present in 49.5% of cases; 31.7% of cases had a pneumonia and 90.2% was treated with antibiotics.

Conclusions: This case-control study in a primary care setting in sub-Saharan Africa found influenza virus A and B, RSV, and S pneumoniae to be the main causes of acute respiratory tract infections in children below 5 years of age. We recommend evaluation of antibiotics prescription behaviour in this setting.

简介:虽然急性呼吸道感染是全世界儿童死亡和发病的主要原因,但由于卫生、疫苗接种和抗生素耐药性等因素,病原体模式会发生变化。人们缺乏对当前呼吸道感染原因的了解,特别是在低收入和中等收入国家。本研究的目的是确定在塞内加尔郊区初级保健诊所就诊的5岁以下儿童中引起急性呼吸道感染的各种呼吸道病原体。方法:于2018年9月和10月进行病例对照研究。采集病例口咽拭子;有发热和呼吸道症状的婴儿及其控制;参与疫苗接种计划的儿童。采用聚合酶链反应对21种不同的病毒进行了病毒鉴定;细菌是通过培养研究鉴定出来的。微生物、急性呼吸道感染和疾病严重程度之间的关联通过多变量回归计算,调整混杂因素如年龄、性别和居住区域。结果:共纳入102例,对照组96例。90.1%的病例和53.7%的对照组检出微生物(P型肺炎链球菌与急性呼吸道感染独立相关)。49.5%的病例中存在两种或两种以上病原体的共同检测;31.7%的病例发生肺炎,90.2%的病例使用抗生素治疗。结论:这项在撒哈拉以南非洲初级保健机构进行的病例对照研究发现,甲型和乙型流感病毒、呼吸道合胞病毒和肺炎链球菌是5岁以下儿童急性呼吸道感染的主要原因。我们建议对这种情况下的抗生素处方行为进行评估。
{"title":"Pathogens Causing Respiratory Tract Infections in Children Less Than 5 Years of Age in Senegal.","authors":"Rebecca B Knobbe,&nbsp;Abdallah Diallo,&nbsp;Amary Fall,&nbsp;Aida D Gueye,&nbsp;Assane Dieng,&nbsp;Tabitha D van Immerzeel,&nbsp;Abou Ba,&nbsp;Amadou Diop,&nbsp;Abdoulaye Diop,&nbsp;Mbayame Niang,&nbsp;Cheikh Sb Boye","doi":"10.1177/1178636119890885","DOIUrl":"https://doi.org/10.1177/1178636119890885","url":null,"abstract":"<p><strong>Introduction: </strong>While acute respiratory tract infections are the main cause of paediatric mortality and morbidity worldwide, pathogen patterns shift due to factors such as hygiene, vaccinations, and antibiotic resistance. Knowledge about current cause of respiratory infections is lacking, particularly in low- and middle-income countries. The aim of this study was to identity the various respiratory pathogens causing acute respiratory tract infections in children below 5 years of age visiting a sub-urban primary care clinic in Senegal.</p><p><strong>Methods: </strong>A case-control study was performed in September and October 2018. Oropharyngeal swabs were collected from cases; infants with fever and respiratory symptoms, and controls; children involved in the vaccination programme. Viral identification was conducted by polymerase chain reaction for 21 different viruses; bacteria were identified by culture studies. Associations between microorganisms, acute respiratory infection and severity of disease were calculated by multivariate regression adjusting for confounders such as age, sex, and living area.</p><p><strong>Results: </strong>Overall, 102 cases and 96 controls were included. Microorganisms were detected in 90.1% of cases and 53.7% of controls (<i>P</i> < .001). Influenza virus A (including H1N1), influenza virus B, respiratory syncytial virus (RSV), and <i>Streptococcus pneumoniae</i> were independently associated with acute respiratory tract infections. Co-detection of two or more pathogens was present in 49.5% of cases; 31.7% of cases had a pneumonia and 90.2% was treated with antibiotics.</p><p><strong>Conclusions: </strong>This case-control study in a primary care setting in sub-Saharan Africa found influenza virus A and B, RSV, and <i>S pneumoniae</i> to be the main causes of acute respiratory tract infections in children below 5 years of age. We recommend evaluation of antibiotics prescription behaviour in this setting.</p>","PeriodicalId":74187,"journal":{"name":"Microbiology insights","volume":"12 ","pages":"1178636119890885"},"PeriodicalIF":0.0,"publicationDate":"2019-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1178636119890885","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37517279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Clinical Characteristics of Influenza in Season 2017/2018 in a German Emergency Department: A Retrospective Analysis. 2017/2018年德国急诊科流感临床特征的回顾性分析
Pub Date : 2019-12-06 eCollection Date: 2019-01-01 DOI: 10.1177/1178636119890302
Sonia Mohammad, Klaus Korn, Barbara Schellhaas, Markus F Neurath, Ruediger S Goertz

Introduction: Influenza infection is a viral disease with significant morbidity and mortality during the cold months. Clinical presentation typically includes cough, fever, and pain. Influenza disease is hardly diagnosed only on the basis of clinical symptoms due to similar clinical presentation of other diseases such as a typical cold or other flu-like diseases. We evaluated patients with proven influenza who presented at an emergency department of internal medicine in a university hospital according to the clinical presentation and different age groups.

Materials and methods: From October 2017 to April 2018, 723 reverse transcription-polymerase chain reaction (RT-PCR) tests for influenza were performed in the emergency department on patients with suspected influenza diagnosed clinically. A total of 240 influenza-positive patients were retrospectively assessed for documented main symptoms, vital parameters, risk factors for an unfavorable course, hospitalization, and death.

Results: The mean age of influenza patients was 65 years. Overall, 30 patients were aged 18 to 39 years, 48 patients 40 to 59 years, and 162 patients ⩾60 years. Influenza B in 168 (70%) was predominant to 72 influenza A (mostly H1N1). In only 30% of the patients all three typical symptoms (cough, fever, and headache/myalgia) were documented. Headache or myalgia (with 34%) was rather uncommon in influenza B. Sudden onset was cited in only 5.4%; 57% of all influenza patients were in hospital for a mean of 7.1 days, and 5.8% of all influenza patients died. Patients aged above 60 years had more risk factors, showed typical symptoms less frequently, and were hospitalized longer than younger patients (<60 and <40 years).

Conclusions: At an emergency department of internal medicine, influenza-diseased patients are of higher age, show an increased number of comorbidities, and are more likely to have milder symptoms documented. Elderly patients with influenza have a higher hospitalization rate with a longer hospital stay as compared with younger patients.

流感感染是一种病毒性疾病,在寒冷的月份发病率和死亡率都很高。临床表现通常包括咳嗽、发热和疼痛。流感疾病很难仅根据临床症状诊断,因为其他疾病(如典型感冒或其他流感样疾病)的临床表现与流感相似。我们根据临床表现和不同年龄组对在大学医院内科急诊科就诊的确诊流感患者进行了评估。材料与方法:对2017年10月至2018年4月在急诊科对临床诊断为疑似流感的患者进行了723例流感逆转录聚合酶链反应(RT-PCR)检测。回顾性评估了240例流感阳性患者的主要症状、重要参数、不利病程的危险因素、住院和死亡。结果:流感患者平均年龄65岁。总体而言,30名患者年龄在18至39岁之间,48名患者年龄在40至59岁之间,162名患者年龄大于或等于60岁。168例(70%)以乙型流感为主,72例(以H1N1为主)以甲型流感为主。只有30%的患者记录了所有三种典型症状(咳嗽、发烧和头痛/肌痛)。头痛或肌痛(占34%)在乙型流感中相当罕见,突发性发作仅为5.4%;57%的流感患者平均住院7.1天,5.8%的流感患者死亡。60岁以上的患者有更多的危险因素,表现出典型症状的频率更低,住院时间比年轻患者更长(结论:在内科急诊科,流感患病患者年龄更高,合并症数量增加,更有可能有较轻的症状记录。与年轻患者相比,老年流感患者的住院率更高,住院时间更长。
{"title":"Clinical Characteristics of Influenza in Season 2017/2018 in a German Emergency Department: A Retrospective Analysis.","authors":"Sonia Mohammad,&nbsp;Klaus Korn,&nbsp;Barbara Schellhaas,&nbsp;Markus F Neurath,&nbsp;Ruediger S Goertz","doi":"10.1177/1178636119890302","DOIUrl":"https://doi.org/10.1177/1178636119890302","url":null,"abstract":"<p><strong>Introduction: </strong>Influenza infection is a viral disease with significant morbidity and mortality during the cold months. Clinical presentation typically includes cough, fever, and pain. Influenza disease is hardly diagnosed only on the basis of clinical symptoms due to similar clinical presentation of other diseases such as a typical cold or other flu-like diseases. We evaluated patients with proven influenza who presented at an emergency department of internal medicine in a university hospital according to the clinical presentation and different age groups.</p><p><strong>Materials and methods: </strong>From October 2017 to April 2018, 723 reverse transcription-polymerase chain reaction (RT-PCR) tests for influenza were performed in the emergency department on patients with suspected influenza diagnosed clinically. A total of 240 influenza-positive patients were retrospectively assessed for documented main symptoms, vital parameters, risk factors for an unfavorable course, hospitalization, and death.</p><p><strong>Results: </strong>The mean age of influenza patients was 65 years. Overall, 30 patients were aged 18 to 39 years, 48 patients 40 to 59 years, and 162 patients ⩾60 years. Influenza B in 168 (70%) was predominant to 72 influenza A (mostly H1N1). In only 30% of the patients all three typical symptoms (cough, fever, and headache/myalgia) were documented. Headache or myalgia (with 34%) was rather uncommon in influenza B. Sudden onset was cited in only 5.4%; 57% of all influenza patients were in hospital for a mean of 7.1 days, and 5.8% of all influenza patients died. Patients aged above 60 years had more risk factors, showed typical symptoms less frequently, and were hospitalized longer than younger patients (<60 and <40 years).</p><p><strong>Conclusions: </strong>At an emergency department of internal medicine, influenza-diseased patients are of higher age, show an increased number of comorbidities, and are more likely to have milder symptoms documented. Elderly patients with influenza have a higher hospitalization rate with a longer hospital stay as compared with younger patients.</p>","PeriodicalId":74187,"journal":{"name":"Microbiology insights","volume":"12 ","pages":"1178636119890302"},"PeriodicalIF":0.0,"publicationDate":"2019-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1178636119890302","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37459636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Identification of AcrAB-TolC Efflux Pump Genes and Detection of Mutation in Efflux Repressor AcrR from Omeprazole Responsive Multidrug-Resistant Escherichia coli Isolates Causing Urinary Tract Infections. 奥美拉唑反应性尿路感染多药耐药大肠埃希菌acrabb - tolc外排泵基因鉴定及外排抑制因子AcrR突变检测
Pub Date : 2019-12-04 eCollection Date: 2019-01-01 DOI: 10.1177/1178636119889629
Nandan Chowdhury, Sabrina Suhani, Auditi Purkaystha, Musammat Kulsuma Begum, Topu Raihan, Md Jahangir Alam, Kamrul Islam, Abul Kalam Azad

Antimicrobial resistance poses a threat in the treatment of infectious diseases in Bangladesh as well as in the world. Multidrug-resistant (MDR) Enterobacteriaceae, the most common cause of one such infectious disease, urinary tract infection (UTI), has contributed to the escalating problem of selecting empiric antibiotics against UTIs. The aim of this study was to investigate the presence of the efflux pump in MDR Escherichia coli isolates from UTI in the North-East region of Bangladesh, to isolate and characterize the AcrAB-TolC efflux pump genes of these locally isolated strains and to do mutation analysis of the efflux pump repressor AcrR gene to understand the AcrAB-TolC efflux pump mechanism. In the presence of omeprazole, an efflux pump inhibitor, every MDR E. coli isolate showed increased susceptibility to at least 1 of the 7 antibiotics investigated, indicating that efflux pump might be involved in their antibiotic resistance. Omeprazole decreased the minimum inhibitory concentration of every antibiotics being investigated by 2- to 8-fold. DNA and the deduced amino acid sequences of the polymerase chain reaction (PCR) products analyzed by bioinformatics tools revealed that the chromosomal AcrAB-TolC and AcrR genes were present in all MDR and antibiotic-susceptible E. coli isolates. However, the deduced amino acid sequences of the amplification refractory mutation system (ARMS) PCR product of the AcrR gene revealed that the substitution of arginine to cysteine at position 45 of AcrR was observed only in the MDR E. coli whose antibiotic susceptibility increased in the presence of omeprazole. Data reported herein support the notion that the increased antibiotic susceptibility of the MDR E. coli isolates in the presence of omeprazole might be due to efflux pump(s) inhibition and the AcrAB-TolC efflux pump might be a contributor to antibiotic resistance when the mutation of arginine to cysteine occurs at position 45 of AcrR.

抗菌素耐药性对孟加拉国以及全世界的传染病治疗构成威胁。多药耐药(MDR)肠杆菌科是泌尿道感染(UTI)这类传染病的最常见病因,它导致了针对UTI选择经验性抗生素的问题不断升级。本研究的目的是调查孟加拉国东北地区尿路感染多药耐药大肠杆菌中是否存在外排泵,分离并表征这些当地分离菌株的AcrAB-TolC外排泵基因,并对外排泵抑制因子AcrR基因进行突变分析,以了解AcrAB-TolC外排泵机制。在外排泵抑制剂奥美拉唑的存在下,每个MDR大肠杆菌分离株对所研究的7种抗生素中的至少1种表现出敏感性增加,表明外排泵可能参与了它们的抗生素耐药性。奥美拉唑使所研究的每一种抗生素的最低抑菌浓度降低2- 8倍。利用生物信息学工具分析聚合酶链反应(PCR)产物的DNA和推导出的氨基酸序列显示,在所有耐多药和抗生素敏感的大肠杆菌分离株中均存在AcrAB-TolC和AcrR基因。然而,AcrR基因扩增难解突变系统(ARMS) PCR产物的氨基酸序列显示,AcrR基因45位的精氨酸被半胱氨酸取代,仅在耐多药大肠杆菌中观察到,其抗生素敏感性在奥美拉唑存在下增加。本文报道的数据支持这样一种观点,即当奥美拉唑存在时,耐多药大肠杆菌分离株的抗生素敏感性增加可能是由于外排泵的抑制,而acrabb - tolc外排泵可能是当AcrR 45位发生精氨酸到半胱氨酸的突变时,抗生素耐药性的一个因素。
{"title":"Identification of <i>AcrAB-TolC</i> Efflux Pump Genes and Detection of Mutation in Efflux Repressor <i>AcrR</i> from Omeprazole Responsive Multidrug-Resistant <i>Escherichia coli</i> Isolates Causing Urinary Tract Infections.","authors":"Nandan Chowdhury,&nbsp;Sabrina Suhani,&nbsp;Auditi Purkaystha,&nbsp;Musammat Kulsuma Begum,&nbsp;Topu Raihan,&nbsp;Md Jahangir Alam,&nbsp;Kamrul Islam,&nbsp;Abul Kalam Azad","doi":"10.1177/1178636119889629","DOIUrl":"https://doi.org/10.1177/1178636119889629","url":null,"abstract":"<p><p>Antimicrobial resistance poses a threat in the treatment of infectious diseases in Bangladesh as well as in the world. Multidrug-resistant (MDR) Enterobacteriaceae, the most common cause of one such infectious disease, urinary tract infection (UTI), has contributed to the escalating problem of selecting empiric antibiotics against UTIs. The aim of this study was to investigate the presence of the efflux pump in MDR <i>Escherichia coli</i> isolates from UTI in the North-East region of Bangladesh, to isolate and characterize the AcrAB-TolC efflux pump genes of these locally isolated strains and to do mutation analysis of the efflux pump repressor <i>AcrR</i> gene to understand the AcrAB-TolC efflux pump mechanism. In the presence of omeprazole, an efflux pump inhibitor, every MDR <i>E. coli</i> isolate showed increased susceptibility to at least 1 of the 7 antibiotics investigated, indicating that efflux pump might be involved in their antibiotic resistance. Omeprazole decreased the minimum inhibitory concentration of every antibiotics being investigated by 2- to 8-fold. DNA and the deduced amino acid sequences of the polymerase chain reaction (PCR) products analyzed by bioinformatics tools revealed that the chromosomal <i>AcrAB-TolC</i> and <i>AcrR</i> genes were present in all MDR and antibiotic-susceptible <i>E. coli</i> isolates. However, the deduced amino acid sequences of the amplification refractory mutation system (ARMS) PCR product of the <i>AcrR</i> gene revealed that the substitution of arginine to cysteine at position 45 of AcrR was observed only in the MDR <i>E. coli</i> whose antibiotic susceptibility increased in the presence of omeprazole. Data reported herein support the notion that the increased antibiotic susceptibility of the MDR <i>E. coli</i> isolates in the presence of omeprazole might be due to efflux pump(s) inhibition and the AcrAB-TolC efflux pump might be a contributor to antibiotic resistance when the mutation of arginine to cysteine occurs at position 45 of AcrR.</p>","PeriodicalId":74187,"journal":{"name":"Microbiology insights","volume":"12 ","pages":"1178636119889629"},"PeriodicalIF":0.0,"publicationDate":"2019-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1178636119889629","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37459635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 22
Inhaled Amphotericin B as Aspergillosis Prophylaxis in Hematologic Disease: An Update 吸入两性霉素B预防血液病曲霉菌病的研究进展
Pub Date : 2019-08-01 DOI: 10.1177/1178636119869937
Madison J Duckwall, M. Gales, B. J. Gales
This review summarizes the literature on inhaled amphotericin B for invasive aspergillosis prophylaxis in patients with neutropenia secondary to hematologic malignancy treatment or stem cell transplant. Six trials, 2 randomized controlled and 4 with historical controls, were identified. Three inhaled amphotericin B deoxycholate trials found a reduced invasive aspergillosis incidence, 1 reaching statistical significance. Three inhaled liposomal amphotericin B trials demonstrated similar reductions with 2 finding statistical significance. Relative risk reductions for invasive aspergillosis were routinely 40-60%. Both formulations were without reported systemic or severe adverse effects. The most common adverse events were cough, bad taste, and nausea. Discontinuation rates ranged from 0-45%. The only randomized, placebo-controlled trial utilized inhaled liposomal amphotericin B reported a nearly 60% relative risk reduction. Inhaled liposomal amphotericin B 12.5 mg twice weekly is an alternative for invasive aspergillosis prophylaxis in high risk neutropenic patients with hematologic malignancies and stem cell transplant recipients when recommended azole agents are contraindicated or should not be used.
本文综述了吸入两性霉素B预防血液系统恶性肿瘤治疗或干细胞移植继发中性粒细胞减少症患者侵袭性曲霉菌病的文献。确定了6项试验,2项为随机对照,4项为历史对照。三项吸入两性霉素B脱氧胆酸盐的试验发现侵袭性曲霉菌病的发病率降低,1达到统计学意义。三项吸入性两性霉素脂质体B试验显示了类似的减少,其中两项具有统计学意义。侵袭性曲霉菌病的相对风险通常降低40-60%。两种制剂均未报告系统性或严重不良反应。最常见的不良事件是咳嗽、味觉不好和恶心。停药率在0-45%之间。唯一一项使用吸入性两性霉素脂质体B的随机安慰剂对照试验报告了近60%的相对风险降低。当推荐的唑类药物禁用或不应使用时,吸入两性霉素B 12.5 mg脂质体,每周两次,可用于血液系统恶性肿瘤的高危中性粒细胞减少患者和干细胞移植受者的侵袭性曲霉菌病预防。
{"title":"Inhaled Amphotericin B as Aspergillosis Prophylaxis in Hematologic Disease: An Update","authors":"Madison J Duckwall, M. Gales, B. J. Gales","doi":"10.1177/1178636119869937","DOIUrl":"https://doi.org/10.1177/1178636119869937","url":null,"abstract":"This review summarizes the literature on inhaled amphotericin B for invasive aspergillosis prophylaxis in patients with neutropenia secondary to hematologic malignancy treatment or stem cell transplant. Six trials, 2 randomized controlled and 4 with historical controls, were identified. Three inhaled amphotericin B deoxycholate trials found a reduced invasive aspergillosis incidence, 1 reaching statistical significance. Three inhaled liposomal amphotericin B trials demonstrated similar reductions with 2 finding statistical significance. Relative risk reductions for invasive aspergillosis were routinely 40-60%. Both formulations were without reported systemic or severe adverse effects. The most common adverse events were cough, bad taste, and nausea. Discontinuation rates ranged from 0-45%. The only randomized, placebo-controlled trial utilized inhaled liposomal amphotericin B reported a nearly 60% relative risk reduction. Inhaled liposomal amphotericin B 12.5 mg twice weekly is an alternative for invasive aspergillosis prophylaxis in high risk neutropenic patients with hematologic malignancies and stem cell transplant recipients when recommended azole agents are contraindicated or should not be used.","PeriodicalId":74187,"journal":{"name":"Microbiology insights","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1178636119869937","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45508028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
The Expanding Role of p38 Mitogen-Activated Protein Kinase in Programmed Host Cell Death p38丝裂原活化蛋白激酶在程序性宿主细胞死亡中的扩展作用
Pub Date : 2019-07-01 DOI: 10.1177/1178636119864594
Jessica Gräb, J. Rybniker
The p38 mitogen-activated protein kinase (MAPK) is involved in a multitude of essential cellular processes. The kinase is activated in response to environmental stresses, including bacterial infections and inflammation, to regulate the immune response of the host. However, recent studies have demonstrated that pathogens can manipulate p38 MAPK signaling for their own benefit to either prevent or induce host cell apoptosis. In addition, there is evidence demonstrating that p38 MAPK is a potent trigger of pathogen-induced necrosis driven by mitochondrial membrane disruption. Given the large number of p38 MAPK inhibitors that have been tested in clinical trials, these findings provide an opportunity to repurpose these drugs for improved control of infectious diseases.
p38丝裂原活化蛋白激酶(MAPK)参与了许多重要的细胞过程。该激酶在环境压力下被激活,包括细菌感染和炎症,以调节宿主的免疫反应。然而,最近的研究表明,病原体可以为自己的利益操纵p38 MAPK信号,以防止或诱导宿主细胞凋亡。此外,有证据表明p38 MAPK是由线粒体膜破坏驱动的病原体诱导的坏死的有效触发因素。鉴于大量的p38 MAPK抑制剂已经在临床试验中进行了测试,这些发现为重新利用这些药物来改善传染病的控制提供了机会。
{"title":"The Expanding Role of p38 Mitogen-Activated Protein Kinase in Programmed Host Cell Death","authors":"Jessica Gräb, J. Rybniker","doi":"10.1177/1178636119864594","DOIUrl":"https://doi.org/10.1177/1178636119864594","url":null,"abstract":"The p38 mitogen-activated protein kinase (MAPK) is involved in a multitude of essential cellular processes. The kinase is activated in response to environmental stresses, including bacterial infections and inflammation, to regulate the immune response of the host. However, recent studies have demonstrated that pathogens can manipulate p38 MAPK signaling for their own benefit to either prevent or induce host cell apoptosis. In addition, there is evidence demonstrating that p38 MAPK is a potent trigger of pathogen-induced necrosis driven by mitochondrial membrane disruption. Given the large number of p38 MAPK inhibitors that have been tested in clinical trials, these findings provide an opportunity to repurpose these drugs for improved control of infectious diseases.","PeriodicalId":74187,"journal":{"name":"Microbiology insights","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1178636119864594","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47297693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
Unraveling Escherichia coli’s Cloak: Identification of Phosphoethanolamine Cellulose, Its Functions, and Applications 揭开大肠杆菌的外衣:磷酸乙醇胺纤维素的鉴定,其功能和应用
Pub Date : 2019-07-01 DOI: 10.1177/1178636119865234
J. Jeffries, G. Fuller, L. Cegelski
Bacterial biofilms are complex, multicellular communities made up of bacteria enmeshed in a self-produced extracellular matrix (ECM) that protects against environmental stress. The ECM often comprises insoluble components, which complicates the study of biofilm composition, structure, and function. Wrinkled, agar-grown Escherichia coli biofilms require 2 insoluble macromolecules: curli amyloid fibers and cellulosic polymers. We quantified these components with solid-state nuclear magnetic resonance (NMR) and determined that curli contributed 85% of the isolated uropathogenic E coli ECM dry mass. The remaining 15% was cellulosic, but, surprisingly, was not ordinary cellulose. We tracked the identity of the unanticipated peak in the 13C NMR spectrum of the cellulosic component and discovered that E coli secrete phosphoethanolamine (pEtN)-modified cellulose. Cellulose is the most abundant biopolymer on the planet, and this marked the first identification of a naturally, chemically modified cellulose. To investigate potential roles of pEtN cellulose, we customized a newly designed live-cell monolayer rheometer and demonstrated that pEtN cellulose facilitated E coli attachment to bladder epithelial cells and acted as a glue, keeping curli cell associated. The discovery of pEtN cellulose opens questions regarding its biological function(s) and provides opportunities in materials science to explore this newly discovered biopolymer.
细菌生物膜是一种复杂的多细胞群落,由嵌入自我产生的细胞外基质(ECM)中的细菌组成,可以抵御环境压力。ECM通常包含不溶性成分,这使生物膜组成、结构和功能的研究变得复杂。褶皱的琼脂生长的大肠杆菌生物膜需要两种不溶性大分子:curli淀粉样蛋白纤维和纤维素聚合物。我们用固态核磁共振(NMR)对这些成分进行了定量,并确定curli占分离的尿路致病大肠杆菌ECM干物质的85%。其余15%是纤维素,但令人惊讶的是,它不是普通纤维素。我们追踪了纤维素成分的13C NMR光谱中出乎意料的峰的身份,发现大肠杆菌分泌磷酸乙醇胺(pEtN)修饰的纤维素。纤维素是地球上最丰富的生物聚合物,这标志着首次鉴定出一种天然的化学改性纤维素。为了研究pEtN纤维素的潜在作用,我们定制了一种新设计的活细胞单层流变仪,并证明pEtN纤维促进了大肠杆菌与膀胱上皮细胞的粘附,并起到了粘合剂的作用,使curli细胞保持关联。pEtN纤维素的发现引发了人们对其生物功能的质疑,并为材料科学探索这种新发现的生物聚合物提供了机会。
{"title":"Unraveling Escherichia coli’s Cloak: Identification of Phosphoethanolamine Cellulose, Its Functions, and Applications","authors":"J. Jeffries, G. Fuller, L. Cegelski","doi":"10.1177/1178636119865234","DOIUrl":"https://doi.org/10.1177/1178636119865234","url":null,"abstract":"Bacterial biofilms are complex, multicellular communities made up of bacteria enmeshed in a self-produced extracellular matrix (ECM) that protects against environmental stress. The ECM often comprises insoluble components, which complicates the study of biofilm composition, structure, and function. Wrinkled, agar-grown Escherichia coli biofilms require 2 insoluble macromolecules: curli amyloid fibers and cellulosic polymers. We quantified these components with solid-state nuclear magnetic resonance (NMR) and determined that curli contributed 85% of the isolated uropathogenic E coli ECM dry mass. The remaining 15% was cellulosic, but, surprisingly, was not ordinary cellulose. We tracked the identity of the unanticipated peak in the 13C NMR spectrum of the cellulosic component and discovered that E coli secrete phosphoethanolamine (pEtN)-modified cellulose. Cellulose is the most abundant biopolymer on the planet, and this marked the first identification of a naturally, chemically modified cellulose. To investigate potential roles of pEtN cellulose, we customized a newly designed live-cell monolayer rheometer and demonstrated that pEtN cellulose facilitated E coli attachment to bladder epithelial cells and acted as a glue, keeping curli cell associated. The discovery of pEtN cellulose opens questions regarding its biological function(s) and provides opportunities in materials science to explore this newly discovered biopolymer.","PeriodicalId":74187,"journal":{"name":"Microbiology insights","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1178636119865234","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42928089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
The Massachusetts Hepatitis C Testing Cascade, 2014-2016. 马萨诸塞州丙型肝炎检测级联,2014-2016。
Pub Date : 2019-06-21 eCollection Date: 2019-01-01 DOI: 10.1177/1178636119857961
Quynh T Vo, Shauna Onofrey, Daniel Church, Kevin Cranston, Alfred DeMaria, R Monina Klevens

Objectives: To characterize hepatitis C testing in Massachusetts and guide stakeholders in addressing the needs of people living with hepatitis C.

Methods: All persons with a positive laboratory report for anti-hepatitis C virus (HCV) antibody, between 2014 and 2016, were included in the testing cascade. Outcomes were HCV tests received after a positive anti-HCV antibody test: nucleic acid test or genotype test. Logistic regression analyses were performed to determine factors associated with progression through the HCV testing cascade.

Results: Among those reported anti-HCV antibody positive, a total of 13 194 (61%) cases had a subsequent RNA-based test, and 79% (10 374/13 194) were confirmed with current, active HCV infection. For confirmed HCV cases, 44% (4557/10 374) had a genotype identified. The median time from an antibody-positive test to a RNA-based test was 29 days (interquartile range [IQR] = 7-151). Differences in moving through the testing cascade were observed by birth cohort and race/ethnicity.

Conclusions: Improved surveillance capture of demographic information is needed to help public health agencies ensure equity in HCV diagnosis and linkage to care.

目的:了解马萨诸塞州丙型肝炎检测的特点,并指导利益相关者解决丙型肝炎患者的需求。方法:在2014年至2016年期间,所有抗丙型肝炎病毒(HCV)抗体实验室报告阳性的人都被纳入检测级联。结果是抗HCV抗体检测阳性后接受HCV检测:核酸检测或基因型检测。通过HCV检测级联进行逻辑回归分析以确定与进展相关的因素。结果:在报告的抗HCV抗体阳性患者中,共有13194例(61%)进行了随后的基于rna的检测,其中79%(10374 / 13194)被确认为当前的活动性HCV感染。在确诊的HCV病例中,44%(4557/ 10374)有确定的基因型。从抗体阳性检测到rna检测的中位时间为29天(四分位数间距[IQR] = 7-151)。不同的出生队列和种族/民族观察到在测试级联中移动的差异。结论:需要改进人口统计信息的监测,以帮助公共卫生机构确保丙型肝炎病毒诊断的公平性和与护理的联系。
{"title":"The Massachusetts Hepatitis C Testing Cascade, 2014-2016.","authors":"Quynh T Vo,&nbsp;Shauna Onofrey,&nbsp;Daniel Church,&nbsp;Kevin Cranston,&nbsp;Alfred DeMaria,&nbsp;R Monina Klevens","doi":"10.1177/1178636119857961","DOIUrl":"https://doi.org/10.1177/1178636119857961","url":null,"abstract":"<p><strong>Objectives: </strong>To characterize hepatitis C testing in Massachusetts and guide stakeholders in addressing the needs of people living with hepatitis C.</p><p><strong>Methods: </strong>All persons with a positive laboratory report for anti-hepatitis C virus (HCV) antibody, between 2014 and 2016, were included in the testing cascade. Outcomes were HCV tests received after a positive anti-HCV antibody test: nucleic acid test or genotype test. Logistic regression analyses were performed to determine factors associated with progression through the HCV testing cascade.</p><p><strong>Results: </strong>Among those reported anti-HCV antibody positive, a total of 13 194 (61%) cases had a subsequent RNA-based test, and 79% (10 374/13 194) were confirmed with current, active HCV infection. For confirmed HCV cases, 44% (4557/10 374) had a genotype identified. The median time from an antibody-positive test to a RNA-based test was 29 days (interquartile range [IQR] = 7-151). Differences in moving through the testing cascade were observed by birth cohort and race/ethnicity.</p><p><strong>Conclusions: </strong>Improved surveillance capture of demographic information is needed to help public health agencies ensure equity in HCV diagnosis and linkage to care.</p>","PeriodicalId":74187,"journal":{"name":"Microbiology insights","volume":"12 ","pages":"1178636119857961"},"PeriodicalIF":0.0,"publicationDate":"2019-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1178636119857961","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37377796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Change in the Composition of Trichoderma reesei Carbohydrases Complex as a Result of Gamma Mutagenesis. 伽马诱变对里氏木霉糖酶复合物组成的影响。
Pub Date : 2019-05-27 eCollection Date: 2019-01-01 DOI: 10.1177/1178636119848368
Elena V Kostyleva, Anna S Sereda, Dmitrii O Osipov, Irina A Velikoretskaya, Nina V Tsurikova

The filamentous fungus Trichoderma reesei is traditionally used as the main industrial producer of cellulases and hemicellulases. Recently, the relevance of carbohydrases hydrolyzing nonstarch polysaccharides of cereals has significantly increased in feed production. In processing of grain raw materials, endodepolymerases, mainly xylanases and endoglucanases, play a key role. Earlier, we carried out gamma mutagenesis of an industrial strain T. reesei BCM18.2/KK to increase the proportion of endodepolymerases in its enzyme complex. Endoglucanase activity of the strain was increased 5-fold, while xylanase activity increased more than 8-fold. It was interesting to determine the carbohydrases composition in enzyme preparations obtained from the original and mutant T. reesei strains. So, the strains were cultured in laboratory fermenters; concentrated preparations were obtained using freeze dryer. It was established that gamma mutagenesis resulted in significant changes in the carbohydrases complex of the strain. Cellobiohydrolase I being the major carbohydrase in the original strain was absent in the enzyme complex of the mutant. The share of xylanases and endoglucanases in the preparation from the mutant strain increased by 6% and 6.5%, respectively, compared with the preparation from the original strain. The obtained data show the ability of gamma irradiation to affect the component composition of T. reesei carbohydrase complex.

传统上,丝状真菌里氏木霉被用作纤维素酶和半纤维素酶的主要工业生产者。近年来,糖酶水解谷物非淀粉多糖在饲料生产中的应用显著增加。在粮食原料加工过程中,以木聚糖酶和内切葡聚糖酶为主的内解聚合酶起着关键作用。在此之前,我们对一株工业菌株T. reesei BCM18.2/KK进行了γ诱变,以增加其酶复合物中内解聚合酶的比例。内切葡聚糖酶活性提高了5倍,木聚糖酶活性提高了8倍以上。从原始菌株和突变菌株获得的酶制剂中测定糖酶的组成是很有趣的。因此,菌株在实验室发酵罐中培养;用冷冻干燥机得到浓缩制剂。结果表明,伽马诱变导致菌株糖酶复合物发生显著变化。纤维素生物水解酶I是原菌株的主要糖酶,在突变体的酶复合体中缺失。与原始菌株相比,突变菌株制备的木聚糖酶和内切葡聚糖酶的含量分别增加了6%和6.5%。所获得的数据表明,伽马辐射的能力,以影响糖酶复合物的组成。
{"title":"The Change in the Composition of <i>Trichoderma reesei</i> Carbohydrases Complex as a Result of Gamma Mutagenesis.","authors":"Elena V Kostyleva,&nbsp;Anna S Sereda,&nbsp;Dmitrii O Osipov,&nbsp;Irina A Velikoretskaya,&nbsp;Nina V Tsurikova","doi":"10.1177/1178636119848368","DOIUrl":"https://doi.org/10.1177/1178636119848368","url":null,"abstract":"<p><p>The filamentous fungus <i>Trichoderma reesei</i> is traditionally used as the main industrial producer of cellulases and hemicellulases. Recently, the relevance of carbohydrases hydrolyzing nonstarch polysaccharides of cereals has significantly increased in feed production. In processing of grain raw materials, endodepolymerases, mainly xylanases and endoglucanases, play a key role. Earlier, we carried out gamma mutagenesis of an industrial strain <i>T. reesei</i> BCM18.2/KK to increase the proportion of endodepolymerases in its enzyme complex. Endoglucanase activity of the strain was increased 5-fold, while xylanase activity increased more than 8-fold. It was interesting to determine the carbohydrases composition in enzyme preparations obtained from the original and mutant <i>T. reesei</i> strains. So, the strains were cultured in laboratory fermenters; concentrated preparations were obtained using freeze dryer. It was established that gamma mutagenesis resulted in significant changes in the carbohydrases complex of the strain. Cellobiohydrolase I being the major carbohydrase in the original strain was absent in the enzyme complex of the mutant. The share of xylanases and endoglucanases in the preparation from the mutant strain increased by 6% and 6.5%, respectively, compared with the preparation from the original strain. The obtained data show the ability of gamma irradiation to affect the component composition of <i>T. reesei</i> carbohydrase complex.</p>","PeriodicalId":74187,"journal":{"name":"Microbiology insights","volume":"12 ","pages":"1178636119848368"},"PeriodicalIF":0.0,"publicationDate":"2019-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1178636119848368","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37061048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Inverse Associations of Schistosoma mansoni Infection and Metabolic Syndromes in Humans: A Cross-Sectional Study in Northeast Ethiopia. 人类曼氏血吸虫感染与代谢综合征的负相关:埃塞俄比亚东北部的一项横断面研究
Pub Date : 2019-05-22 eCollection Date: 2019-01-01 DOI: 10.1177/1178636119849934
Mistire Wolde, Nega Berhe, Girmay Medhin, Feyissa Chala, Irma van Die, Aster Tsegaye

Background: Recent animal and retrospective human studies have demonstrated that Schistosoma mansoni infection may have potential to protect against development of metabolic syndromes. Thus, the aim of this study was to assess metabolic panel among S. mansoni egg positives and egg negatives in stool examinations. This study was a cross-sectional study, conducted involving 120 participants from S. mansoni endemic town (Kemise) and 61 from non-endemic town (Kombolcha), Northeast Ethiopia. Stool samples were collected and examined for S. mansoni and other helminths using Kato-Katz method. Furthermore, blood samples were collected and used for determination of blood sugar, lipid profile tests, insulin, and C-reactive protein. Data were analyzed using SPSS software version 20. Chi-square test, independent mean t-test, and logistic regression models were employed on data. P values less than .05 were considered as statistically significant.

Results: S. mansoni infected participants (n = 41; all from Kemise) had significantly lower levels of fasting blood sugar, low prevalence of dyslipidemia (at least one or more abnormal lipid profile tests; total cholesterol, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], and triglycerides) as compared with controls (n = 79 in Kemise and 61 in Kombolcha). Moreover, logistic regression model indicated that with the adjusted odds ratios, there was significant inverse association between S. mansoni infection and impaired fasting glucose (adjusted odds ratio -0.181, 95% confidence interval: 0.042-0.774).

Conclusions: Low fasting blood sugar and reduced prevalence of dyslipidemia in S. mansoni egg positive participants might suggest inverse association of S. mansoni infection and development of metabolic syndromes. Furthermore, large-scale studies are recommended to assess the role of S. mansoni egg and/or worm antigens in modulating the host metabolic profile and reducing the risk of metabolic syndromes, including diabetes mellitus and cardiovascular diseases.

背景:最近的动物和回顾性人体研究表明,曼氏血吸虫感染可能具有预防代谢综合征发展的潜力。因此,本研究的目的是评估粪便检查中曼氏梭菌卵阳性和卵阴性的代谢组。本研究是一项横断面研究,涉及来自埃塞俄比亚东北部曼索尼血吸虫流行城镇(Kemise)的120名参与者和来自非流行城镇(Kombolcha)的61名参与者。收集粪便样本,采用加藤-卡茨法检测曼氏梭菌和其他蠕虫。此外,收集血液样本并用于测定血糖、脂质谱测试、胰岛素和c反应蛋白。数据分析采用SPSS软件第20版。数据采用卡方检验、独立均值t检验和logistic回归模型。P值小于0.05被认为具有统计学意义。结果:mansoni感染参与者(n = 41;均来自Kemise)空腹血糖水平明显较低,血脂异常患病率较低(至少有一项或多项异常血脂检测;总胆固醇、低密度脂蛋白胆固醇[LDL-C]、高密度脂蛋白胆固醇[HDL-C]和甘油三酯)与对照组(Kemise组n = 79, Kombolcha组n = 61)相比。此外,logistic回归模型显示,经校正的比值比,曼氏梭菌感染与空腹血糖受损呈显著负相关(校正比值比为-0.181,95%可信区间为0.042-0.774)。结论:低空腹血糖和降低血脂异常患病率的曼氏梭菌卵阳性参与者可能提示曼氏梭菌感染与代谢综合征的发展呈负相关。此外,建议进行大规模研究,以评估曼氏梭菌卵和/或蠕虫抗原在调节宿主代谢谱和降低代谢综合征(包括糖尿病和心血管疾病)风险方面的作用。
{"title":"Inverse Associations of <i>Schistosoma mansoni</i> Infection and Metabolic Syndromes in Humans: A Cross-Sectional Study in Northeast Ethiopia.","authors":"Mistire Wolde,&nbsp;Nega Berhe,&nbsp;Girmay Medhin,&nbsp;Feyissa Chala,&nbsp;Irma van Die,&nbsp;Aster Tsegaye","doi":"10.1177/1178636119849934","DOIUrl":"https://doi.org/10.1177/1178636119849934","url":null,"abstract":"<p><strong>Background: </strong>Recent animal and retrospective human studies have demonstrated that <i>Schistosoma mansoni</i> infection may have potential to protect against development of metabolic syndromes. Thus, the aim of this study was to assess metabolic panel among <i>S. mansoni</i> egg positives and egg negatives in stool examinations. This study was a cross-sectional study, conducted involving 120 participants from <i>S. mansoni</i> endemic town (Kemise) and 61 from non-endemic town (Kombolcha), Northeast Ethiopia. Stool samples were collected and examined for <i>S. mansoni</i> and other helminths using Kato-Katz method. Furthermore, blood samples were collected and used for determination of blood sugar, lipid profile tests, insulin, and C-reactive protein. Data were analyzed using SPSS software version 20. Chi-square test, independent mean t-test, and logistic regression models were employed on data. <i>P</i> values less than .05 were considered as statistically significant.</p><p><strong>Results: </strong><i>S. mansoni</i> infected participants (n = 41; all from Kemise) had significantly lower levels of fasting blood sugar, low prevalence of dyslipidemia (at least one or more abnormal lipid profile tests; total cholesterol, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], and triglycerides) as compared with controls (n = 79 in Kemise and 61 in Kombolcha). Moreover, logistic regression model indicated that with the adjusted odds ratios, there was significant inverse association between <i>S. mansoni</i> infection and impaired fasting glucose (adjusted odds ratio -0.181, 95% confidence interval: 0.042-0.774).</p><p><strong>Conclusions: </strong>Low fasting blood sugar and reduced prevalence of dyslipidemia in <i>S. mansoni</i> egg positive participants might suggest inverse association of <i>S. mansoni</i> infection and development of metabolic syndromes. Furthermore, large-scale studies are recommended to assess the role of <i>S. mansoni</i> egg and/or worm antigens in modulating the host metabolic profile and reducing the risk of metabolic syndromes, including diabetes mellitus and cardiovascular diseases.</p>","PeriodicalId":74187,"journal":{"name":"Microbiology insights","volume":"12 ","pages":"1178636119849934"},"PeriodicalIF":0.0,"publicationDate":"2019-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1178636119849934","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37074535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
期刊
Microbiology insights
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1